Introduction
infection
ASYMPTOMATIC COVID-19, INFECTION
Effective, safe, well-tolerated, and inexpensive oral antiviral agents are needed for the early treatment of COVID-19. Monoclonal antibodies, mainly directed against the SARS-CoV-2 spike protein, have proved effective in preventing and treating COVID-19 (Early in the COVID-19 pandemic, considerable attention was focussed on available drugs that might have useful antiviral activity (To resolve the uncertainty over efficacy, we measured the in vivo antiviral activity of high-dose ivermectin in previously healthy adults with early symptomatic COVID-19 infection.